**What are the findings?**

1.  Long-term exercise significantly alters the plasma miRNA profile of healthy young women.

2.  Long-term exercise may reduce the risk of lung, breast, pancreas, esophageal, thyroid neoplasms, melanoma and cholangiocarcinoma by regulating circulating miRNAs.

3.  Athletes may have a higher risk of heart failure and coronary artery disease.

Introduction {#S1}
============

MicroRNAs (miRNAs) are small non-coding RNAs with approximately 22 nucleotides in length. Their function is to degrade the targeted messenger RNAs (mRNAs) or inhibit their translation by binding to the complementary region of the mRNA molecules, which in turn participate in various biological or pathological processes ([@B11]). They are found to be abundant and stable in biofluids, including blood serum/plasma ([@B17]), cerebrospinal fluid (CSF) ([@B9]; [@B70]; [@B2]), milk ([@B52]), saliva ([@B8]), and urine ([@B16]). These miRNAs in the biofluids are called circulating miRNAs (ci-miRNAs) and may come from dead cells or as by-products of routine microvesicle secretion or specifically secreted by cells ([@B76]). The levels of ci-miRNAs will change under different physio- or pathological conditions, such as pregnancy ([@B62]), myocardial infarction ([@B13]), muscle injury ([@B19]), liver damage ([@B40]), diabetes ([@B57]), and cancer ([@B78]).

A few studies have shown that plasma ci-miRNAs can also be affected by a single bout of acute exercise ([@B7]; [@B6]; [@B56]; [@B18]; [@B65]; [@B10]) or sustained training from 28 to 140 days ([@B7]; [@B6]; [@B56]; [@B42]; [@B10]). Most of them focused on some specific ci-miRNAs, such as ci-miRNAs involved in inflammation, skeletal and cardiac muscle contractility, and hypoxia/ischemia adaptation ([@B7]), muscle-enriched miRNAs ([@B6]), miRNAs related to cardiovascular disease ([@B10]), and those involved in angiogenesis and inflammation and are enriched in muscle and/or cardiac tissues ([@B42]). Only one study ([@B56]) quantified the expression levels of 188 known ci-miRNAs in the plasma of 32 healthy, trained men before and after 12 weeks of endurance exercise and found nine miRNAs expressed differently. By far, the response of whole ci-miRNAs in plasma to long-term exercise (\>5 years), especially among long-term trained professional athletes, remains unknown. In this study, we chose athletes of a Synchronized Swimming Group as our subjects since the movement difference between players is small and the team members usually have years of regular exercise experience. We compared the total plasma miRNAs of 10 players from a Synchronized Swimming Group and 15 female college students without regular exercise experience, using second-generation sequencing technology, to study the impact of long-term exercise on the plasma miRNA content.

Materials and Methods {#S2}
=====================

Subjects {#S2.SS1}
--------

The participants were 10 Synchronized Swimming Group members and 15 female college students of Guangdong Pharmaceutical University. All participants were informed of the methods, procedures, and risks, and then they signed an informed consent document, which was approved by the Ethics Committee of South China Normal University School of Sports Science (approval number 2017102001).

MiRNA Isolation From Plasma {#S2.SS2}
---------------------------

Blood samples were collected around 7:00 a.m., and participants did not have breakfast or vigorous exercise for 24 h. Whole blood (10 ml) from subjects was collected *via* a direct venous puncture into tubes with ethylenediaminetetraacetic acid (EDTA) as an anticoagulant. Blood was put on ice for half an hour and then separated by 2,000 rpm for 10 min at 4°C. Then, the plasma was transferred to an RNase-free tube and stored at −80°C. The RNA samples were extracted with a TRIzol reagent (Life Technologies, cat. no. 15596018). The purity and concentration of the RNA samples were assessed with Nanodrop and Qubit 2.0. RNA integrity was assessed using the RNA Nano 6000 Assay Kit of the Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, United States) to ensure the use of qualified samples for sequencing.

MiRNA Sequencing {#S2.SS3}
----------------

RNA samples undergo a series of strict quality control. Qualified samples are used for library construction. Library construction is strictly in accordance with NEBNext Ultra Small RNA Sample Library Prep Kit for Illumina, qualified libraries for high-throughput sequencing. The sequencing platform was Illumina HiSeq X Ten, and read length was single-end (SE) 50 nt.

Data Analysis {#S2.SS4}
-------------

### Quality Control {#S2.SS4.SSS1}

Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter or ploy-N and low-quality reads from raw data. The reads were trimmed and cleaned by removing the sequences smaller than 15 nt or longer than 35 nt. At the same time, Q20, Q30, GC content, and the sequence duplication level of the clean data were calculated. All the downstream analyses were based on clean data with high quality.

### Comparative Analysis {#S2.SS4.SSS2}

Using Bowtie software, analysis of the clean reads was done, respectively, with the Silva database, GtRNAdb database, Rfam database, and Repbase database for sequence alignment, filter ribosomal RNA (rRNA), transfer RNA (tRNA), small nuclear RNA (snRNA), small nucleolar RNA (snoRNA), and other ncRNAs and repeats. The remaining reads were used to detect known miRNAs and novel miRNAs predicted by comparing with Genome and known miRNAs from miRBase. Randfold software was used for novel miRNA secondary structure prediction.

### Differential Expression Analysis {#S2.SS4.SSS3}

The expression of miRNAs in each sample was counted and normalized by the Trusted Platform Module (TPM) algorithm ([@B23]). The normalization formula for TPM is as follows: TPM = Actual miRNA read count/Total miRNA read count × 1,000,000. Differential expression analysis was performed using the DESeq R package (1.10.1). The resulting *P* values were adjusted using the Benjamini and Hochberg's approach for controlling the false discovery rate (FDR). MiRNAs with \|log~2~(FC, fold change)\| ≥ 1 and FDR \< 0.05 found by DESeq were assigned as differentially expressed miRNAs.

### Target Gene Functional Annotation {#S2.SS4.SSS4}

Target gene prediction was done using miRanda (Doron [@B22]) and RNAhybrid ([@B58]). Gene function was annotated based on the following databases: Nr (NCBI non-redundant protein sequences), Pfam (Protein family), KOG/COG (Clusters of Orthologous Groups of proteins), Swiss-Prot (a manually annotated and reviewed protein sequence database), KEGG (KEGG Ortholog database), and GO (Gene Ontology).

### Enrichment Analysis {#S2.SS4.SSS5}

A GO term enrichment analysis^[1](#footnote1){ref-type="fn"}^ was used to identify the biological processes, molecular functions, and cellular components associated with the target genes of differential expression miRNAs. KEGG pathway enrichment analysis^[2](#footnote2){ref-type="fn"}^ was used to identify the miRNA targets associated with signaling pathways in the S vs. the C group.

### MiRNAs as Biomarkers of Certain Diseases (Study Selection Criteria) {#S2.SS4.SSS6}

We screened ci-miRNA biomarkers related to certain types of cancers through the Human MicroRNA Disease Database (HMDD^[3](#footnote3){ref-type="fn"}^). Studies were included if they (i) were original research and (ii) evaluated the ci-miRNA levels in a specific disease. Studies were excluded if they were published in a language other than English and are review articles, book chapters, conference abstracts, editorials/commentaries/expert opinion, theses, or dissertations.

Results {#S3}
=======

The Expression Patterns of Ci-MiRNAs Were Highly Similar Within the Originally Divided Participants {#S3.SS1}
---------------------------------------------------------------------------------------------------

The participants included 10 Synchronized Swimming Group members (S group) and 15 female college students from Guangdong Pharmaceutical University in China (C group). The average age of these 10 players was 19.1 years compared with 19.4 years of the control, and there was no significant age difference between these two groups (19.1 ± 2.08 vs. 19.4 ± 0.83 years, *P* = 0.67). The subjects were all healthy and without known diseases. C group members had no exercise habit and did not enroll in any long-term sports or dancing in the last 5 years. For details, see [Supplementary Table 1](#TS1){ref-type="supplementary-material"}. Pearson's correlation coefficient was used to test the similarity of these samples at a global level ([Figure 1](#F1){ref-type="fig"}). The heat map of the correlations between each sample was generated and showed distinct expression pattern between the two groups. The clustering of samples showed that the same group of samples is very similar to the groups of samples originally divided.

![Heat maps of the Pearson's correlation coefficients for different samples. When the linear relationship between the two variables is enhanced, the correlation coefficient tends to be 1 or --1. A positive correlation tends to be 1, while a negative correlation tends to be --1.](fphys-11-00372-g001){#F1}

Differentially Expressed MiRNAs Between the S and C Groups {#S3.SS2}
----------------------------------------------------------

Twenty-five specimens were successfully sequenced by using Illumina Genome Analyzer II. The number of raw reads obtained per specimen ranged from 15,872,436 to 32,103,564 (average = 23,148,465). From the raw reads, an average of 22,508,866 clean reads (ranging from 15,569,728 to 31,145,335) were filtered and mapped to human genome. After analyzing and normalizing all the mapped reads in both groups, we identified the existence of 3,531 miRNAs with 1,733 known miRNAs and 1,798 novel miRNAs. Then, we applied a stringent filtering criterion to differentiate S and C (FDR \< 0.05, \| log~2~(FC)\| ≥ 1) and identified 380 miRNAs that were differentially expressed (for details, see [Supplementary Table 2](#TS2){ref-type="supplementary-material"}). Specifically, 238 miRNAs were upregulated and 142 were downregulated ([Figure 2A](#F2){ref-type="fig"}). In addition, 23 miRNAs have an extremely significant difference between the two groups (\| log~2~(FC)\| ≥ 5) ([Figure 2B](#F2){ref-type="fig"}). Notably, all 23 miRNAs were upregulated in the S group, and the highest differentially expressed miRNA was novel-miR-1150 (\| log~2~(FC)\| = 8.09). Among the 380 differentially expressed miRNAs, the five most abundant in the S group were miR-451a, miR-486, miR-423-5p, let-7b-5p, and miR-21-5p, with \| log~2~(FC)\| = 4.77, 4.76, 2.13, 2.65, and 1.53 and TPM = 224,122, 119,250, 85,314, 43,867, and 26,667, respectively. On the other hand, the five most abundant miRNAs in the C group were miR-21-5p, let-7f-5p, miR-148a-3p, miR-423-5p, and miR-146a-5p. Taken together, there are consistent and significant differences in the plasma miRNA profiles between the athlete group and the normal college student group.

![**(A)** Volcano plot of the differentially expressed miRNAs. The plot shows the log~2~ fold change on the *X*-axis vs. the adjusted *P* values (on the log10 scale) on the *Y*-axis. *Red dots* indicate upregulated miRNAs, *green dots* are downregulated miRNAs, and *blue dots* are miRNAs with no significant difference. **(B)** Venn diagram of the differentially expressed miRNAs. Each *circle* represents a comparison group. The *overlapping part* is the common miRNAs among the comparison groups.](fphys-11-00372-g002){#F2}

Target Gene Prediction of Differentially Expressed MiRNAs {#S3.SS3}
---------------------------------------------------------

To explore the functions of chronic exercise induced differentially expressed miRNAs, the target genes of these miRNAs were predicted by combining miRanda and RNAhybrid to reduce the probability of false positives. From this analysis, 20,449 target genes corresponding to 3,531 miRNAs were identified. For details, see [Supplementary Table 3](#TS3){ref-type="supplementary-material"}.

Functional Annotation Analysis {#S3.SS4}
------------------------------

Gene ontology enrichment analysis of the 380 differentially expressed genes (DEGs) was implemented by the GOseq R packages based on Wallenius' non-central hyper-geometric distribution. In the S group, 1,162 GO categories of biological processes, 142 of cellular component, and 203 of molecular function were found to be significantly affected (Kolmogorov--Smirnov, KS \< 0.05). The 10 most significantly enriched GO categories of biological processes, cellular component, and molecular function are listed in [Table 1](#T1){ref-type="table"}.

###### 

Top 10 most significantly enriched GO categories of the differentially expressed miRNAs.

  GO ID                      Term                                                        Annotated   Significant   Expected   KS
  -------------------------- ----------------------------------------------------------- ----------- ------------- ---------- ----------
  **Biological processes**                                                                                                    
  GO:0007411                 Axon guidance                                               397         377           347.57     1.9E-12
  GO:0071586                 CAAX-box protein processing                                 26          26            22.76      7.6E-10
  GO:1900246                 Positive regulation of RIG-I signaling pathway              27          27            23.64      3.7E-09
  GO:0045944                 Positive regulation of transcription by RNA polymerase II   849         793           743.3      6.2E-09
  GO:1900245                 Positive regulation of MDA-5 signaling pathway              26          26            22.76      9E-09
  GO:0050691                 Regulation of defense response to virus by host             55          54            48.15      1.1E-08
  GO:0031064                 Negative regulation of histone deacetylation                25          25            21.89      2.2E-08
  GO:0090315                 Negative regulation of protein targeting to membrane        27          26            23.64      3.8E-08
  GO:0090084                 Negative regulation of inclusion body assembly              12          11            10.51      6.4E-07
  GO:0001525                 Angiogenesis                                                406         386           355.45     1.00E-06
  **Molecular functions**                                                                                                     
  GO:0030054                 Cell junction                                               879         831           767.72     2.30E-08
  GO:0005737                 Cytoplasm                                                   10,110      9,044         8,830.1    5.80E-08
  GO:0005667                 Transcription factor complex                                353         330           308.31     3.60E-07
  GO:0005634                 Nucleus                                                     6,542       5,808         5,713.8    4.00E-06
  GO:0045202                 Synapse                                                     559         520           488.23     1.70E-05
  GO:0005583                 Fibrillar collagen trimer                                   26          26            22.71      3.10E-05
  GO:0005604                 Basement membrane                                           99          95            86.47      4.60E-05
  GO:0005874                 Microtubule                                                 380         355           331.89     6.30E-05
  GO:0072357                 PTW/PP1 phosphatase complex                                 13          13            11.35      8.50E-05
  GO:0045211                 Postsynaptic membrane                                       213         199           186.03     0.00017
  **Cellular components**                                                                                                     
  GO:0043565                 Sequence-specific DNA binding                               746         711           651.87     3.80E-11
  GO:0003700                 DNA-binding transcription factor activity                   1,119       1,034         977.8      7.80E-09
  GO:0008134                 Transcription factor binding                                536         494           468.37     7.10E-08
  GO:0046872                 Metal ion binding                                           4,280       3,837         3,739.9    8.60E-08
  GO:0044212                 Transcription regulatory region DNA binding                 406         396           354.77     1.60E-06
  GO:0003779                 Actin binding                                               381         368           332.92     9.00E-06
  GO:0005524                 ATP binding                                                 1,605       1,458         1,402.5    1.70E-05
  GO:0005515                 Protein binding                                             8,322       7456          7,271.9    1.90E-05
  GO:0005543                 Phospholipid binding                                        533         500           465.75     2.00E-05
  GO:0005488                 Binding                                                     12,839      11,463        11,219     2.10E-05

GO.ID

, ID of the GO term;

Term

, GO function description;

Annotated

, the number of genes annotated with this function;

Significant

, the number of differentially expressed miRNA target genes annotated to this function;

Expected

, the expected number of differentially expressed miRNA target genes annotated to this function;

KS

statistical significance of the enrichment term (the smaller the KS value, the more significant the enrichment).

Pathway Annotation Analysis {#S3.SS5}
---------------------------

Pathway annotation analysis of the differentially expressed miRNA target genes was done using the KEGG database see text footnote 2). The results are shown in [Figure 3](#F3){ref-type="fig"}.

![KEGG pathway enrichment bubble plot of the differentially expressed miRNAs. *X*-axis label represents rich factor (rich factor = amount of differentially expressed genes enriched in the pathway/amount of all genes in the background gene set) and *Y*-axis label represents pathway. The *size* and *color of the bubble* represent the amount of differentially expressed genes enriched in the pathway and the enrichment significance (*Q*\_ value is the *P* value corrected after multiple hypothesis testing), respectively.](fphys-11-00372-g003){#F3}

Circulating MiRNAs as Biomarkers of Different Diseases {#S3.SS6}
------------------------------------------------------

We screened ci-miRNA biomarkers related to certain types of diseases through the HMDD. The results are shown in [Table 2](#T2){ref-type="table"}.

###### 

Ci-miRNA biomarkers related to certain diseases (HMDD database).

                            miR-21                                                                                               miR-146a              miR-126                 miR-423                       Risk
  ------------------------- ---------------------------------------------------------------------------------------------------- --------------------- ----------------------- ----------------------------- ------
  Lung neoplasms            UP ([@B44]; [@B84]; [@B55])                                                                                                                                                      ↓
  Breast neoplasms          UP ([@B83]; [@B63]; [@B34]; [@B66]; [@B5]; [@B30]; [@B45]; [@B47]; [@B75]; [@B46]; [@B54]; [@B72])   UP ([@B34]; [@B46])                                                         ↓
  Pancreatic neoplasms      UP ([@B4]; [@B1]; [@B68]; [@B26])                                                                                                                                                ↓
  Melanoma                                                                                                                       UP ([@B41]; [@B61])                                                         ↓
  Cholangiocarcinoma        UP ([@B67]; [@B43])                                                                                                                                                              ↓
  Esophageal neoplasms      UP ([@B14]; [@B35]; [@B73])                                                                                                                                                      ↓
  Colorectal carcinoma      UP ([@B31]; [@B12]; [@B79]; [@B82]; [@B86])                                                                                                                                      ↓
  Coronary artery disease                                                                                                                              DOWN ([@B24]; [@B80])                                 ↑
  Heart failure                                                                                                                                                                UP ([@B74]; [@B25]; [@B21])   ↑
  S group vs. C group       DOWN                                                                                                 DOWN                  DOWN                    UP                            

UP and DOWN represent the miRNA being increased or decreased, respectively, in the indicated disease compared with the control. "↓," "↑," or "---" indicate the risk that exercise may reduce, increase, or unknown, respectively.

Discussion {#S4}
==========

Differentially Expressed MiRNAs in Athletes Are Likely Due to Long-Term Exercise {#S4.SS1}
--------------------------------------------------------------------------------

As shown in [Figure 1](#F1){ref-type="fig"}, the expression profiles of the ci-miRNAs in athletes were significantly different from those of college students who had not received any regular sports training. Notably, all the participants from both groups in this study come from different parts of China, eating different food. In addition, there are no immediate training seasons prior to the blood withdrawal in the athlete group. In addition to synchronized swimming, the athletes also underwent strength training and aerobic and anaerobic training. Thus, the differentially expressed miRNAs in the athlete group may be a result of combined exercise training. Altogether, the ci-miRNAs' profile changes in the athlete group are highly likely due to long-term exercise.

Ci-MiRNA Profile Changes in Athletes Are Correlated With Muscle-Enriched MiRNAs {#S4.SS2}
-------------------------------------------------------------------------------

A set of miRNAs, called myo-miRs, have been identified in skeletal muscle and/or the myocardium, including miR-1, miR-133a, miR-133b, miR-206, miR-208a, miR-208b, and miR-499 ([@B50]; [@B15]; [@B77]; [@B69]). Their expression is at least 20-fold higher than the mean expression value of the other tissues ([@B38]). Among them, miR-206 is skeletal muscle-specific ([@B49]) and miR-208a is cardiac muscle-specific ([@B64]). MiR-486 is also a skeletal muscle and cardiac-enriched miRNA, which was included in myo-miRs in later studies ([@B29]). In our study, miR-1 was not detected in all samples. the TPMs of the remaining myo-miRs are shown in [Table 3](#T3){ref-type="table"}.

###### 

Expression level changes of myo-miRs in the athlete group.

  miRNAs        TPM (S group)   TPM (C group)   Regulated
  ------------- --------------- --------------- -----------
  miR-133a-3p   18.7            28.5            No
  miR-133b      0.43            0.63            No
  miR-206       11.7            5.26            Up
  miR-208       0.02            0               No
  miR-208b      0.15            0.2             No
  miR-486-3p    688.45          62.86           Up
  miR-486       119,167.2       7,499.67        Up
  miR-499       17.81           8.22            No

To test whether the level changes of the other differently expressed miRNAs were associated with muscle-specific/enriched miRNAs, we first calculated a Pearson's correlation coefficient between miR-486 and the other differently expressed miRNAs. As a myo-miR, miR-486 mainly functions as a regulator of myoblast proliferation and migration ([@B3]) and skeletal muscle size ([@B28]). The results showed that a large portion of the differently expressed miRNAs (\>30%, R^2^ \> 0.6) were highly correlated with miR-486-5p and miR-486-3p (for details, see [Supplementary Table 4](#TS4){ref-type="supplementary-material"}), which provide another evidence that the miRNA profile changes in the athlete group were likely to be induced by exercise.

Muscle injures are common among athletes. In the plasma of healthy young men, the expression level of miR-206 was significantly higher after high-intensity intermittent exercise (HIIE) or vigorous-intensity continuous exercise (VICE) ([@B18]). miR-206 is also increased in the serum of mdx and CXMDJ mice ([@B51]) or in response to cardiotoxin (CTX)-induced injury, but markedly decreased from day 3 to day 5 after CTX injury ([@B48]). This suggests that high levels of miR-206 in plasma may be associated with skeletal muscle injury. In addition, miR-133 has also been demonstrated to be associated with skeletal muscle injury ([@B37]). In the present study, miR-206 was slightly increased in the S group (\|log~2~FC\| = 1.99, TPM = 0--42.44), and miR-133 did not show significant difference between the two groups. To examine whether the level changes of miRNAs in the athlete group were also associated with muscle injury, we also calculated Pearson's correlation coefficient between miR-206 and the other differently expressed miRNAs and found that there were less than 3% of the differentially expressed miRNAs correlated with muscle injury (\<3%, R^2^ \> 0.6; for details, see [Supplementary Table 4](#TS4){ref-type="supplementary-material"}).

Long-Term Exercise May Reduce the Risk of Cancers by Regulating Ci-MiRNAs {#S4.SS3}
-------------------------------------------------------------------------

Physical activity has been shown to be associated with lower cancer risks. From 30 to 60 min/day of moderate- to vigorous-intensity physical activity can decrease the risk of breast cancer, and physically active individuals have a lower risk of lung cancer ([@B39]). The overall cancer incidence was lower in athletes than in the general population ([@B60]; [@B71]). And former college athletes had a significantly lower risk of breast cancer than do the non-athletes ([@B81]). However, the underlying mechanism regarding exercise reducing cancer risks remains to be discovered. Lately, a number of studies have indicated that some of the ci-miRNAs (see [Table 2](#T2){ref-type="table"}) can be used as biomarkers for cancer or other diseases ([@B33]; [@B85]; [@B27]; [@B32]). Strikingly, long-term exercise regulates the levels of these ci-miRNAs in an opposite direction to those in cancer patients, which suggests that long-term exercise may reduce the risk of cancers through regulating ci-miRNAs.

Interestingly, some of the elevated miRNAs, such as miR-126 and miR-423, in heart failure and coronary artery disease (CAD) were also upregulated in the athlete group. Coronary artery calcification (CAC) is a strong predictor of incident CAD ([@B20]). In a prospective study, 27% higher odds of CAC have been seen among participants who exceeded physical activity guidelines vs. those below physical activity guidelines ([@B36]). CAD is also a leading cause of sudden cardiac death in athletes over 35 years of age ([@B53]). But the incidence rates of sports-related sudden cardiac deaths in noncompetitive and competitive athletes are not different ([@B59]). Does high-intensity or volume exercise increase the risk of CAD? Is miR-126 not a solid biomarker of CAD? Further research is needed to address these questions.

Conslusion {#S5}
==========

Long-term exercise significantly alters the plasma miRNA profiles in healthy young women, which may reduce the risk of lung, breast, pancreas, melanoma, cholangiocarcinoma, esophageal neoplasms, and colorectal carcinoma. Our current study described an overall effect of long-term exercise on circulating miRNA profiles in the plasma of young women. Further studies are needed to determine whether different types of exercises have different effects on ci-miRNAs and whether there are gender and age differences.
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